Nicola Klein to Product Surveillance, Postmarketing
This is a "connection" page, showing publications Nicola Klein has written about Product Surveillance, Postmarketing.
Connection Strength
2.960
-
Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D) in infants and children. Vaccine. 2018 04 12; 36(16):2133-2138.
Score: 0.550
-
Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers. Vaccine. 2016 07 29; 34(35):4172-4179.
Score: 0.489
-
An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women. Vaccine. 2012 Jun 29; 30(31):4585-7.
Score: 0.367
-
Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in a United States health maintenance organization. Pediatr Infect Dis J. 2010 Jul; 29(7):613-7.
Score: 0.323
-
A review of methodologic & data considerations for vaccine safety surveillance in the wake of the COVID-19 pandemic. Vaccine. 2025 Oct 03; 64:127691.
Score: 0.231
-
Postlicensure safety surveillance of congenital anomaly and miscarriage among pregnancies exposed to quadrivalent human papillomavirus vaccine. Hum Vaccin Immunother. 2018 02 01; 14(2):412-419.
Score: 0.135
-
Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine. Vaccine. 2017 12 14; 35(49 Pt B):6879-6884.
Score: 0.133
-
An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015. Pediatr Infect Dis J. 2015 Sep; 34(9):983-91.
Score: 0.115
-
Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine. 2014 May 23; 32(25):3019-24.
Score: 0.105
-
Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study. Am J Epidemiol. 2013 Jan 15; 177(2):131-41.
Score: 0.096
-
Safety of quadrivalent human papillomavirus vaccine administered routinely to females. Arch Pediatr Adolesc Med. 2012 Dec; 166(12):1140-8.
Score: 0.095
-
Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. Vaccine. 2011 Oct 26; 29(46):8279-84.
Score: 0.088
-
The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics. 2011 May; 127 Suppl 1:S45-53.
Score: 0.085
-
Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2007 Sep; 26(9):771-7.
Score: 0.066
-
Risk of Preterm or Small-for-Gestational-Age Birth After Influenza Vaccination During Pregnancy: Caveats When Conducting Retrospective Observational Studies. Am J Epidemiol. 2016 08 01; 184(3):176-86.
Score: 0.031
-
The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. Vaccine. 2014 Sep 22; 32(42):5390-8.
Score: 0.027
-
Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA. 2012 Feb 08; 307(6):598-604.
Score: 0.023